组蛋白乳酸化在疾病中的作用及其中药干预
CSTR:
作者:
作者单位:

1)甘肃中医药大学中医临床学院,兰州 730101

作者简介:

通讯作者:

中图分类号:

基金项目:

甘肃省科学技术厅(23JRRA539)资助项目。


The Role of Histone Lactylation in Diseases and Intervention by Traditional Chinese Medicine
Author:
Affiliation:

1)School of Clinical Chinese Medicine, Gansu University of Chinese Medicine, Lanzhou 730101, China;2)Department of Urology and Pelvic Surgery and Andrology, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu 610041, China

Fund Project:

This work was supported by a grant from Gansu Provincial Science and Technology Plan Project (23JRRA539).

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    组蛋白乳酸化是近年发现的翻译后修饰,指乳酸介导的酶促反应将乳酰基团添加至组蛋白赖氨酸残基上。它广泛分布于人体组织,在特定基因转录调控中发挥关键作用,是重要的表观遗传标记。研究显示,不同位点的组蛋白乳酸化可引发多种生物学效应,这些效应是疾病发生发展的关键驱动因素。反之,抑制组蛋白乳酸化可改变疾病进程,成为有潜力的治疗靶点。此外,组蛋白乳酸化与乙酰化、甲基化等其他修饰存在串扰,共同调控疾病进程。乳酸化不仅发生于组蛋白,也发生于非组蛋白。组蛋白乳酸化通过激活特定基因转录重塑代谢表观遗传学,而非组蛋白乳酸化则直接调节酶活性、信号转导及蛋白质稳定性。两者共享乳酸池、修饰酶系统及通路交互,形成协同网络,构建起“组蛋白乳酸化-代谢枢纽-非组蛋白乳酸化”多维调控轴,连接了代谢与表观遗传,解析其拓扑结构有望为精准干预乳酸相关信号通路异常疾病提供新靶点。研究表明,中药可通过调节乳酸代谢及相关酶类调控组蛋白乳酸化,进而影响疾病进程。同时,部分中药复方在耐药性疾病中展现出替代疗法的潜力,深入探索中医药对组蛋白乳酸化的调控对开发新的治疗策略具有重要意义。本文旨在综述组蛋白乳酸化的调控机制,系统归纳组蛋白不同位点的乳酸化与疾病之间的关联,阐述“乳酸-组蛋白乳酸化和功能蛋白乳酸化”领域全景,叙述中药通过调控组蛋白乳酸化治疗疾病的作用机制与研究进展,以深化理解和展望组蛋白乳酸化在疾病中的作用及应用前景。

    Abstract:

    Histone lactylation is a recently identified post-translational modification, wherein lactate mediates the enzymatic addition of lactyl groups to lysine residues on histones. Since its discovery, extensive research has demonstrated that histone lactylation is widely present in human tissues and plays a pivotal role in regulating the transcription of specific genes. Subsequent studies have further established this modification as a widespread epigenetic mark with significant physiological implications. With advancing research, accumulating evidence confirms that lactylation at distinct histone sites elicits diverse biological effects—such as promoting cell proliferation, driving inflammatory responses, and enhancing fibrosis—all of which profoundly influence disease progression and serve as key drivers of disease onset and development. Conversely, inhibiting histone lactylation can alter disease outcomes, positioning histone lactylation as a promising therapeutic target. Moreover, studies have revealed crosstalk between histone lactylation and other post-translational modifications, such as acetylation and methylation, which collectively regulate disease progression. Notably, lactylation occurs not only on histones but also on non-histone proteins. Histone lactylation activates specific gene transcription and reshapes metabolic epigenetics, while non-histone lactylation directly modulates enzyme activity, signal transduction, and protein stability. These two facets form a synergistic network through shared lactate pools, common modifying enzyme systems, and pathway crosstalk, thereby constructing a multi-dimensional regulatory framework—namely, the “histone lactylation-metabolism hub-non-histone lactylation” axis. This architecture bridges metabolism and epigenetics, and deciphering its topological structure may provide novel targets for precise intervention in diseases driven by lactate-mediated signaling hijacking. Traditional Chinese medicine (TCM), grounded in clinical practice, has been shown to regulate histone lactylation by modulating lactate metabolism and lactylation-related enzymes, thereby influencing disease progression. Moreover, certain TCM formulations exhibit potential as alternative therapies for drug-resistant diseases, underscoring the significance of further exploring TCM-mediated regulation of histone lactylation in future therapeutic strategies. This review aims to elucidate the mechanisms underlying histone lactylation, systematically delineate the associations between site-specific histone lactylation and various diseases, present a comprehensive landscape of the “lactate-histone lactylation and functional protein lactylation” axis, and summarize the mechanistic basis and research advances in TCM-mediated regulation of histone lactylation for disease treatment. Additionally, we discuss current challenges in histone lactylation research and propose future directions, ultimately aiming to deepen understanding and broaden perspectives on the roles and therapeutic potential of histone lactylation in disease.

    参考文献
    相似文献
    引证文献
引用本文

张芯,杜洁,李兆桓,高峰.组蛋白乳酸化在疾病中的作用及其中药干预[J].生物化学与生物物理进展,2026,53(4):887-904

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2026-01-14
  • 最后修改日期:2026-04-09
  • 录用日期:2026-03-16
  • 在线发布日期: 2026-03-16
  • 出版日期: 2026-04-28
文章二维码